Dietrich Stephan's bio:

Dr. Stephan is a widely recognized visionary in the field of molecular medicine and currently serves as the President and CEO of the Ignite Institute. He founded the Institute in 2009 in his quest to change the medical paradigm from reactive and generalized to proactive and personalized through the implementation of molecularly informed, tactical solutions. Dr. Stephen is a pioneer in personalized medicine – working for over a decade to develop early diagnostic tests and knowledge-based therapies for the many different subtypes of common human diseases. He has worked on the interface between academia and industry where “translational medicine” occurs. Dr. Stephan has founded a number of companies, including Navigenics, Amnestix, and Aeuon, Inc. Prior to this, Dr. Stephan served as a Senior Investigator and founding Chairman of the Department of Neurogenomics at the non-profit Translational Genomics Research Institute (TGen) in Phoenix, Arizona and later moved into the role of Deputy Director of Discovery Research for the Institute. Stephan and his colleagues were among the first to use the latest genome scanning technologies to identify genetic links for over two dozen diseases, including autism, ALS, sudden infant death syndrome (SIDS) and Alzheimer’s disease. Dr. Stephan has held faculty appointments at Johns Hopkins University, George Washington University and the University of Arizona. He is the author of over 140 scientific publications and has been highlighted twice on the front page of the Wall Street Journal for his contributions to the field of medicine. Dr. Stephan received a B.S. in Biology/Biochemistry from Carnegie Mellon University in 1991 and a Ph.D. in Human Molecular Genetics from the University of Pittsburgh Medical Center in 1996. He completed a fellowship at the National Human Genome Research Institute in 1999. Dr. Stephan is founder of Navigenics, Inc and owns stock.

Dietrich Stephan's posts:

Bridging the Valley of Death, Medical Genetics 2.0, and other Tales of Translational Genomics Research

Holistic molecular scanning of individuals has become a robust strategy to develop new ways to effectively diagnose and treat disease. [MORE]